Propiedad y actividad de insiders de Gain Therapeutics, Inc. (GANX): operaciones de insiders, transacciones del Senado y la Cámara de EE. UU. y acciones en circulación. Sigue cómo operan la acción los directivos y los políticos.
Precio
| Precio | $1.72 |
| Capitalización | $73M |
| Bolsa | NASDAQ |
| País | US |
Operaciones Recientes de Insiders
| Fecha | Insider | Tipo | Acciones | Valor |
|---|---|---|---|---|
| 2026-07-15 | GOLDSTEIN DOV A MD | A-Award | 25,000 | $42K |
| 2026-07-15 | Nicaise Claude | A-Award | 25,000 | $42K |
| 2026-07-15 | Islam Khalid | A-Award | 25,000 | $42K |
| 2026-07-15 | Melincoff Gwen A | A-Award | 25,000 | $42K |
| 2026-07-15 | Riley Jeffrey Scott | A-Award | 25,000 | $42K |
| 2026-07-15 | HASLER HANS PETER | A-Award | 25,000 | $42K |
| 2026-03-24 | Mack Gene | A-Award | 200,000 | $372K |
| 2026-03-24 | Fuggetta Gianluca | A-Award | 50,000 | $93K |
| 2025-06-24 | Islam Khalid | A-Award | 15,000 | $27K |
| 2025-06-24 | Nicaise Claude | A-Award | 15,000 | $27K |
Balance (10 años)
| Año | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Caja y Equivalentes | $400694 | $303320 | $7.5M | $36.9M | $7.3M | $11.8M | $10.4M | $20.8M |
| Inversiones a Corto | 0 | 0 | 0 | 0 | $12.8M | $5.0M | 0 | 0 |
| Cuentas por Cobrar | 0 | $44915 | $8548 | $195448 | $103877 | $242577 | $765763 | $802693 |
| Inventario | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Corrientes | $494638 | $398047 | $9.0M | $37.7M | $21.1M | $17.8M | $11.6M | $22.2M |
| Inmovilizado Material | $305787 | $219348 | $552713 | $1.0M | $804312 | $585177 | $323334 | $409006 |
| Fondo de Comercio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Intangibles | 0 | 0 | 0 | $202609 | $213967 | $193375 | $134268 | $102837 |
| Activos Totales | $811634 | $660286 | $9.6M | $39.0M | $24.1M | $18.6M | $12.1M | $22.8M |
| Cuentas por Pagar | $149333 | $154441 | $961516 | $560479 | $1.6M | $1.3M | $946259 | $825027 |
| Deuda a Corto | 0 | $102107 | $22626 | $103826 | $108135 | $118797 | $110177 | $100869 |
| Pasivos Corrientes | $530786 | $879052 | $2.1M | $2.6M | $4.1M | $4.9M | $3.9M | $3.4M |
| Deuda a Largo | $1.0M | 0 | $715656 | $590468 | $495258 | $449053 | $328327 | $300084 |
| Pasivos Totales | $1.8M | $1.1M | $3.4M | $4.2M | $5.2M | $6.0M | $4.8M | $4.3M |
| Reservas | -$1.3M | -$3.5M | -$7.0M | -$20.9M | -$38.5M | -$60.8M | -$81.2M | -$101.4M |
| Patrimonio Neto | -$950908 | -$449856 | $6.2M | $34.8M | $18.9M | $12.6M | $7.3M | $18.6M |
| Deuda Total | $1.3M | $200950 | $1.3M | $1.6M | $1.3M | $1.0M | $653015 | $732067 |
| Deuda Neta | $904670 | -$102370 | -$6.2M | -$35.3M | -$18.9M | -$15.8M | -$9.7M | -$20.1M |
| Capital Circulante | -$36148 | -$481005 | $6.9M | $35.2M | $17.0M | $12.8M | $7.7M | $18.9M |
Salud financiera
| Deuda / Patrimonio | 0.05 |
| Ratio corriente | 4.36 |
| Piotroski F-Score | 4 |
| Altman Z-Score | 7.04 |
Rentabilidad
| Rentabilidad sobre capital | -161.58% |
| Rentabilidad sobre capital invertido | -157.82% |
| Rentabilidad sobre activos | -130.37% |
| Margen bruto | 0.00% |
| Margen operativo | 0.00% |
| Margen neto | 0.00% |
Empresas relacionadas: ACET · ADAG · CRVO · FBIO · LITS · NRXP · NTRB
Explorar sector: Healthcare · Biotechnology
Más secciones de GANX: Resumen · Financieros · Valoración · Estadísticas · Estimaciones · Técnico · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones